Literature DB >> 35291729

Immune-Mediated Myopathy in a Patient Presenting for Melanoma Resection and Sentinel Lymph Node Biopsy.

Allan R Escher1, Jamie P Hoffman2, Sarah Alfieri3, Bruno Bordoni4, Raymond M Evans2.   

Abstract

Statin-induced necrotizing autoimmune myopathy (SINAM) is a rare side effect in people who are taking a class of drugs called statins. Patients with SINAM will present with subacute severe symmetric proximal muscle weakness. In contrast to more common myopathies, SINAM may not spontaneously resolve with statin discontinuation. These patients may require long-term immunotherapy to limit further disease progression. In this case study, we report a 74-year-old female with SINAM who presented for radical excision of a right upper back melanoma and sentinel lymph node biopsy at an outpatient facility. An anesthetic plan was crafted with the use of a supraglottic airway device without neuromuscular blockade.
Copyright © 2022, Escher et al.

Entities:  

Keywords:  3-hydroxy-3-methylglutaryl-coenzyme a reductase; autoimmune neuromuscular disease; immune-mediated neuropathy; melanoma; sentinel lymph node biopsy; sinam; statin-induced myopathy; statin-induced necrotizing autoimmune myopathy; statins; supraglottic airway

Year:  2022        PMID: 35291729      PMCID: PMC8896259          DOI: 10.7759/cureus.22777

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

Review 1.  Statin-Associated Autoimmune Myopathy.

Authors:  Andrew L Mammen
Journal:  N Engl J Med       Date:  2016-02-18       Impact factor: 91.245

2.  Laparoscopic partial nephrectomy in a patient on simvastatin : Delayed recovery from neuromuscular blockade.

Authors:  E E Abd El-Hakeem; A M Kaki; S A Almazlom; A J Alsayyad
Journal:  Anaesthesist       Date:  2017-03-06       Impact factor: 1.041

Review 3.  Necrotizing autoimmune myopathy.

Authors:  Christina Liang; Merrilee Needham
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 4.  Statin-Associated Autoimmune Myopathy: A Systematic Review of 100 Cases.

Authors:  Salik Nazir; Saroj Lohani; Niranjan Tachamo; Dilliram Poudel; Anthony Donato
Journal:  J Clin Rheumatol       Date:  2017-04       Impact factor: 3.517

Review 5.  Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.

Authors:  Connie B Newman; David Preiss; Jonathan A Tobert; Terry A Jacobson; Robert L Page; Larry B Goldstein; Clifford Chin; Lisa R Tannock; Michael Miller; Geetha Raghuveer; P Barton Duell; Eliot A Brinton; Amy Pollak; Lynne T Braun; Francine K Welty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

6.  Perspective on Trends in Statin Use.

Authors:  William S Weintraub
Journal:  JAMA Cardiol       Date:  2017-01-01       Impact factor: 14.676

7.  Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies.

Authors:  Georgirene D Vladutiu; Paul J Isackson; Kenneth Kaufman; John B Harley; Beth Cobb; Lisa Christopher-Stine; Robert L Wortmann
Journal:  Mol Genet Metab       Date:  2011-07-12       Impact factor: 4.797

8.  Isolated gluteal and paravertebral muscle weakness due to anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody-associated necrotizing autoimmune myopathy.

Authors:  Nicole M McGrath; Clinton P Turner
Journal:  Muscle Nerve       Date:  2016-05-26       Impact factor: 3.217

9.  Effect of statins on skeletal muscle function.

Authors:  Beth A Parker; Jeffrey A Capizzi; Adam S Grimaldi; Priscilla M Clarkson; Stephanie M Cole; Justin Keadle; Stuart Chipkin; Linda S Pescatello; Kathleen Simpson; C Michael White; Paul D Thompson
Journal:  Circulation       Date:  2012-11-26       Impact factor: 29.690

10.  Statin Induced Myopathy Among Patients Attending the National Center for Diabetes, endocrinology, & genetics.

Authors:  Waddah Abed; Mousa Abujbara; Anwar Batieha; Kamel Ajlouni
Journal:  Ann Med Surg (Lond)       Date:  2022-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.